Attached files

file filename
8-K - FORM 8-K - Shire plcdp49836_8k.htm
EXHIBIT 99.1
 
Press Release
www.shire.com
 
 
 
Director Share Dealings

September 30, 2014 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that today Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, have been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from July 1 to September 30, 2014.
 
 
Type of Security (1)
Number of Shares/ADSs
Dominic Blakemore
Shares
98
 
William Burns
Shares
99
 
Dr. Steven Gillis
ADSs
32
 
Dr. David Ginsburg
ADSs
30
 
David Kappler
Shares
104
 
Susan Kilsby
ADSs
100
 
Anne Minto
Shares
104
 
David Stout
ADSs
32
 

(1)              One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at prices of £53.45 per Share and $259.9747 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

 
For further information please contact:

Investor Relations
   
Jeff Poulton
jpoulton@shire.com
+1 781 482 0945
Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157
Media
   
Stephanie Fagan
sfagan@shire.com
+1 781 482 0460
Gwen Fisher
gfisher@shire.com
+1 484 595 9836
 
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

 
 
 

 
 
NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

www.shire.com